Use of Streptococcus salivarius K12 in supporting the mucosal immune function of active young subjects: A randomised double-blind study.
- 2023-03-02
- RCT
- Frontiers in immunology 14
- Alexander Bertuccioli
- Marco Gervasi
- Giosuè Annibalini
- Beatrice Binato
- Fabrizio Perroni
- Marco B L Rocchi
- Davide Sisti
- Stefano Amatori
- PubMed: 36936914
- DOI: 10.3389/fimmu.2023.1129060
- High evidence
- Adults
The number of URTI episodes was similar in the treated and control groups (χ² = 1.83; p > 0.05)
- Effect
- Neutral
- Effect size
- Small
- Significant
- No